Product:

Panvax vaccine

Active Ingredient:

Influenza Virus Type A haemagglutinin 30mcg

Dosage Form:

Suspension for injection

New Zealand Sponsor:

Seqirus (NZ) Limited

Manufacturer:

Seqirus Pty Limited, Melbourne, Australia

Note: This consent is given subject to the following condition:

• The vaccine may only be marketed or distributed in accordance with the directives contained in the current version of the New Zealand Influenza Pandemic Action Plan.

Note: This renewed consent is valid for two years from 6 March 2022.